| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/04/2007 | WO2005112994A8 Nodavirus-vlp immunization composition |
| 01/04/2007 | WO2005110474A3 HUMANIZED FcϜRIIB SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF |
| 01/04/2007 | WO2005035572A3 Antibody compositions and methods |
| 01/04/2007 | WO2005028634A3 Improved mva vaccines |
| 01/04/2007 | US20070005255 Synthetic active peptide fragments |
| 01/04/2007 | US20070004914 enhance humoral and cell-mediated immune responses to vaccine antigens; 2-deoxy-2-amino- beta -D-glucopyranose (glucosamine) glycosidically linked to an cyclic aminoalkyl (aglycon) group; viricide; immunostimulant; antiischemic agent |
| 01/04/2007 | US20070004913 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
| 01/04/2007 | US20070004666 Methods for modulating apoptotic cell death |
| 01/04/2007 | US20070004657 Diagnosis and treatment of kidney fibrosis and other fibrotic diseases |
| 01/04/2007 | US20070004656 transfer the sialic acids from a donor molecule (eg. oligosaccharides) to acceptor molecule (eg. oligo- and polysaccharides); foodstuffs or food additives |
| 01/04/2007 | US20070004632 An isolated BAX gene frameshift-mutation polypeptide is used to stimulate the proliferation of human T cells, T cellular immunity; for treating cancer patient; cancer vaccines |
| 01/04/2007 | US20070004630 Treating cell proliferation disease; aberrant fetoplacental growth; cancer |
| 01/04/2007 | US20070004620 Fp receptor antagonists or pgf2 alpha antagonists for treating pathological conditions of the uterus |
| 01/04/2007 | US20070003972 Detection and treatment of cancers of the lung |
| 01/04/2007 | US20070003610 Application of lipid vehicles and use for drug delivery |
| 01/04/2007 | US20070003580 Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound |
| 01/04/2007 | US20070003579 Allergen-specific immunotherapy |
| 01/04/2007 | US20070003578 Chimeric protein comprising non-toxic pseudomonas exotoxin and type IV pilin sequences |
| 01/04/2007 | US20070003577 Purified trimeric S protein as vaccine against severe acute respiratory syndrome virus infections |
| 01/04/2007 | US20070003576 Vaccines for the rapid response to pandemic avian influenza |
| 01/04/2007 | US20070003575 Viral and viral associated MiRNAs and uses thereof |
| 01/04/2007 | US20070003574 antibody or antiserum directed against a structural protein of Ljungan picornavirus; cardiovascular, nervous system and metabolic disorders; Myocarditis, Cardiomyopathia, Guillain Barre Syndrome, and Diabetes Mellitus, Multiple Sclerosis, Chronic Fatigue Syndrome, Myasthenia Gravis |
| 01/04/2007 | US20070003573 Viral expression vector for use in the treatment and diagnosis of viral, cardiovascular, nervous system and metabolic disorders |
| 01/04/2007 | US20070003572 Polynucleotides and polypeptides encoded by the depicted nucleic acid sequences which may be used as medicaments, vaccines or diagnostic substances, preferably for the treatment, prevention or diagnosis of HIV infections |
| 01/04/2007 | US20070003571 Modified herpes simplex viral particle for targeting and destroying tumor cells |
| 01/04/2007 | US20070003570 Using ORF 5 polypeptide of a VR2332 virus as evaluative tool in diagnosisng porcine reproductive and respiratory syndrome (PRRS) virus infection |
| 01/04/2007 | US20070003569 Recombinant polypeptides, which can be used as purified antigens for the detection and control of tuberculosis |
| 01/04/2007 | US20070003568 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof |
| 01/04/2007 | US20070003567 Composition and methods for enhancing immunogenecity of antigens |
| 01/04/2007 | US20070003566 Polyepitope carrier protein |
| 01/04/2007 | US20070003565 Use of hab18g/cd147 molecule as target for antiviral antagonists and thus obtained antiviral antagonist |
| 01/04/2007 | US20070003564 Diluent for immunohistochemistry |
| 01/04/2007 | US20070003563 Multivalent entrain-and-amplify immunotherapeutics for carcinoma |
| 01/04/2007 | US20070003562 Chimera molecule containing protein and merozoites surface protein; induce immunology response against antigen |
| 01/04/2007 | US20070003561 Binding member towards pneumococcus surface adhesin a protein (psaa) |
| 01/04/2007 | US20070003560 Humanized monoclonal antibodies that protect against shiga toxin induced disease |
| 01/04/2007 | US20070003559 Methods of determining pharmacokinetics of targeted therapies |
| 01/04/2007 | US20070003558 with inhibitors of chemokine receptor (CXCR4); gene expression inhibition; decreases homing of cells to bone marrow and reduces disease development; administered via osmotic pump |
| 01/04/2007 | US20070003557 Method for treating cancer using premedication |
| 01/04/2007 | US20070003556 Modified antibodies against cd22 and utilization thereof |
| 01/04/2007 | US20070003555 Heat shock protein binding fragments of CD91, and uses thereof |
| 01/04/2007 | US20070003554 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha |
| 01/04/2007 | US20070003553 Anticoagulant agents useful in treatment of thrombosis |
| 01/04/2007 | US20070003552 Cross-beta structure comprising amyloid binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fibril formation and for modulating cross-beta structure-mediated toxicity and method for interfering with blood coagulation |
| 01/04/2007 | US20070003551 Immunoglobulin |
| 01/04/2007 | US20070003550 P53 vaccines for the treatment of cancers |
| 01/04/2007 | US20070003549 treatment and prevention of cell proliferative and inflammatory disorders; drug delivery device is for simultaneously administering to a subject anti-VEGF treatment and anti-EGFR treatment |
| 01/04/2007 | US20070003548 Anti-TNF antibodies, compositions, methods and uses |
| 01/04/2007 | US20070003547 Super humanized antibodies |
| 01/04/2007 | US20070003546 engineered glycoform; improved therapeutic properties, reduced risk of immunogenicity, enabling for the alternate production methods |
| 01/04/2007 | US20070003545 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 01/04/2007 | US20070003544 Combination therapy for treatment of autoimmune diseases using b- cell depleting/immunoregulatory antibody combination |
| 01/04/2007 | US20070003543 Low dose histone peptide treatment for autoimmune disorders |
| 01/04/2007 | US20070003542 Methods for treating diseases or conditions with peptide constructs |
| 01/04/2007 | US20070003516 Compounds, compositions and methods for the treatment of poxvirus infections |
| 01/04/2007 | US20070003514 Mono-and bi-functional antibody conjugates as effective adjuvants of protein vaccination |
| 01/04/2007 | US20070003503 Tissue enhancement implant and method |
| 01/04/2007 | US20070003480 Liposomal composition comprising haptotactic peptides |
| 01/04/2007 | CA2617222A1 Peptide derived from prostate-related protein as cancer vaccine candidate for prostate cancer patient who is positive for hla-a3 super-type allele molecule |
| 01/04/2007 | CA2613788A1 Methods and compositions for the prevention and treatment of kidney disease |
| 01/04/2007 | CA2613355A1 A direct drug delivery system based on thermally responsive biopolymers |
| 01/04/2007 | CA2613284A1 Methods and compositions for expressing negative-sense viral rna in canine cells |
| 01/04/2007 | CA2613166A1 Modulation of negative immune regulators and applications for immunotherapy |
| 01/04/2007 | CA2613082A1 Method for identifying modulators of rufy2 useful for treating alzheimer's disease |
| 01/04/2007 | CA2612963A1 Immunogenic compositions comprising nisseria menningitidis capsular saccharide |
| 01/04/2007 | CA2612760A1 Il-1.beta. binding antibodies and fragments thereof |
| 01/04/2007 | CA2612486A1 Anti-cd71 monoclonal antibodies and uses thereof for treating malignant tumour cells |
| 01/04/2007 | CA2612465A1 Delivery of active proteins to the central nervous system using phage vectors |
| 01/04/2007 | CA2612378A1 Methods and compositions for targeting ifnar2 |
| 01/04/2007 | CA2612225A1 Methods and compositions relating to a vaccine against prostate cancer |
| 01/04/2007 | CA2612224A1 Galk1s as modifiers of the pten/akt pathway and methods of use |
| 01/04/2007 | CA2612047A1 Inactivated chimeric vaccines and related methods of use |
| 01/04/2007 | CA2611964A1 Process for manufacturing vaccines |
| 01/04/2007 | CA2585043A1 High affinity antibodies against hmgb1 and methods of use thereof |
| 01/04/2007 | CA2583121A1 Immunogenic compositions of staphylococcus epidermidis polypeptide antigens |
| 01/03/2007 | EP1739177A1 Antibodies against interferon alpha/beta receptor |
| 01/03/2007 | EP1739173A1 Kit for solid cancer diagnosis and medicine for solid cancer therapy |
| 01/03/2007 | EP1739171A1 Novel gene participating in epidermal differentiation and use thereof |
| 01/03/2007 | EP1739167A1 Method of producing virus |
| 01/03/2007 | EP1738765A1 Antigen-drug vehicle enabling transmucosal and transdermal administration and method of inducing mucosal immunity, mucosal vaccine and dds using the same |
| 01/03/2007 | EP1738764A1 Glycopeptides of the V3 loop of gp120 and derivatives; preparation and applications as HIV-1 vaccines. |
| 01/03/2007 | EP1737983A2 Method of inducing immunity against stratum corneum chymotrytic enzyme |
| 01/03/2007 | EP1737961A1 Modified bouganin proteins, cytotoxins and methods and uses thereof |
| 01/03/2007 | EP1737959A2 Stabilised tat antigen and the use thereof for anti-hiv vaccination |
| 01/03/2007 | EP1737958A1 Compositions and methods for inducing anti-tumor immunity |
| 01/03/2007 | EP1737891A1 Anti-p-selectin antibodies |
| 01/03/2007 | EP1737890A2 Immunoglobulin variants outside the fc region |
| 01/03/2007 | EP1737887A2 Bob-1 specific t cells and methods to use |
| 01/03/2007 | EP1737885A2 Method of using adenoviral vectors to induce an immune response |
| 01/03/2007 | EP1737882A1 Peptide inhibitors of metalloproteinase activity |
| 01/03/2007 | EP1737493A2 Inhibitors of insulin-like growth factor receptor -1 for inhibiting tumour cell growth |
| 01/03/2007 | EP1737491A2 MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERS |
| 01/03/2007 | EP1737490A2 Methods of treating autoimmune and inflammatory diseases |
| 01/03/2007 | EP1737489A2 ErbB ANTAGONISTS FOR PAIN THERAPY |
| 01/03/2007 | EP1737488A1 Treatment of fungal infections |
| 01/03/2007 | EP1737487A1 Method for treating autoimmune diseases with antibodies |
| 01/03/2007 | EP1737486A2 Immunising against meningococcal serogroup y using proteins |
| 01/03/2007 | EP1737485A2 Mucinous glycoprotein (muc-1) vaccine |
| 01/03/2007 | EP1737481A2 Peptides of il1 beta and tnf alpha and method of treatment using same |
| 01/03/2007 | EP1737453A2 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of skin diseases or disorders |